SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-001204
Filing Date
2018-08-01
Accepted
2018-08-01 16:05:35
Documents
1
Period of Report
2018-07-30

Document Format Files

Seq Description Document Type Size
1 form4-08012018_040820.html 4  
1 form4-08012018_040820.xml 4 4058
  Complete submission text file 0001415889-18-001204.txt   5357
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
AHMED NADIM (Reporting) CIK: 0001731193 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 18984753